Option Care Health (OPCH) FY2019 results: revenue $2.3 billion, up 19.1% on the year
Option Care Health, Inc. (OPCH) reported revenue of $2.3 billion for fiscal 2019, the year ended 31 December 2019, up 19.1% on the year before. Net income was -$76 million, and diluted earnings per share $-0.49. The figures are the company's own, from the 10-K it filed with the SEC on 5 March 2020.
Revenue
$2.3 billion
+19.1% on the year
FY2007FY2019
Operating margin
-0.0%
2.0% a year earlier
FY2007FY2019
Net income
-$76 million
FY2007FY2019
Diluted EPS
-$0.49
FY2007FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
2,310
1,940
1,828
+19.1%
Cost of revenue
1,797
466
548
+285.8%
Gross profit
513
422
446
+21.5%
Gross margin
22.2%
21.8%
24.4%
Selling, general and administrative
460
346
338
+32.9%
Operating income
-0.3
38.3
27.3
Operating margin
-0.0%
2.0%
1.5%
Interest expense
73.7
45.8
n/a
+60.9%
Pre-tax income
-78.2
-51.0
-67.4
Income tax
-2.3
-2.7
-18.6
Net income
-75.9
-6.1
3.9
Net margin
-3.3%
-0.3%
0.2%
Diluted EPS
-$0.49
-$0.49
-$0.60
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
39.5
24.4
37.9
+61.6%
Capital expenditure
28.3
26.3
25.0
+7.7%
Free cash flow
11.2
-1.8
12.9
Free cash flow margin
0.5%
-0.1%
0.7%
Cash from investing
-728
-37.0
-24.5
Cash from financing
719
-4.2
-5.2
Depreciation and amortisation
53.7
38.1
34.7
+41.1%
Share-based compensation
4.2
2.1
1.5
+95.0%
Diluted shares, weighted
156m
n/a
n/a
Shares outstanding at period end
177m
128m
n/a
+37.9%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
907
603
n/a
+50.4%
Debt
1,286
539
n/a
+138.5%
Operating lease liabilities
58.2
0.0
n/a
Other liabilities
338
286
n/a
+18.2%
Total liabilities and equity
2,590
1,428
n/a
+81.3%
Fixed assets
133
93.1
n/a
+43.0%
Goodwill
1,426
632
n/a
+125.4%
Intangible assets
386
10.5
n/a
+3,585.9%
Cash and equivalents
67.1
36.4
n/a
+84.3%
Receivables
324
310
n/a
+4.6%
Inventory
116
83.3
n/a
+39.0%
Other assets
138
262
n/a
-47.5%
Total assets
2,590
1,428
n/a
+81.3%
10-K for the year ended 31 December 2019, filed 5 March 2020: the filing.